BBC雙語(yǔ)新聞：國(guó)藥集團(tuán)mpox疫苗獲準(zhǔn)進(jìn)入臨床試驗(yàn)

00:00

00:00

MP3下載

https://online2.tingclass.net/puttext/Upload/20240910/CRP-095804c120hDqV.mp3

https://image.tingclass.net/statics/js/2012

BBC新聞服務(wù)一直以其客觀性、公正性和準(zhǔn)確性而備受贊譽(yù)。多年來，BBC新聞以其高質(zhì)量的新聞報(bào)道和深度分析，為觀眾提供了獲取世界最新動(dòng)態(tài)的重要渠道。整理了近期實(shí)時(shí)相關(guān)資訊：國(guó)藥集團(tuán)mpox疫苗獲準(zhǔn)進(jìn)入臨床試驗(yàn)的相關(guān)內(nèi)容中英文對(duì)照版，幫助大家更好的學(xué)習(xí)英語(yǔ)！

英文原文

The country's top drug regulator has cleared a mpox vaccine developed by Chinese drugmaker Sinopharm for clinical trial on Monday, which could be the nation's first experimental dose to battle the deadly disease, according to the company.

據(jù)該公司介紹，周一，中國(guó)國(guó)家藥品監(jiān)督管理局已批準(zhǔn)中國(guó)藥企國(guó)藥集團(tuán)研發(fā)的mpox疫苗進(jìn)入臨床試驗(yàn)階段，這可能是中國(guó)首款用于抗擊這種致命疾病的試驗(yàn)性疫苗。

The domestic vaccine candidate, created by the Shanghai Institute of Biological Products and administered by Sinopharm, is expected to play an important role in preventing and controlling mpox infections, the company said in a statement released on Monday afternoon.

國(guó)藥集團(tuán)在周一下午發(fā)布的一份聲明中表示，這款由上海生物制品研究所研制、國(guó)藥集團(tuán)負(fù)責(zé)管理的國(guó)產(chǎn)候選疫苗有望在預(yù)防和控制mpox感染方面發(fā)揮重要作用。

In China, a vaccine candidate typically goes through three phases of clinical trials before gaining market approval. The process can take years, even decades, but the National Medical Products Administration, China's top drug regulator, has launched a number of accelerated or streamlined channels to facilitate applications of novel drugs and vaccines or those in urgent need.

在中國(guó)，候選疫苗通常需要經(jīng)過三個(gè)階段的臨床試驗(yàn)才能獲得市場(chǎng)批準(zhǔn)。這一流程可能需要數(shù)年甚至數(shù)十年時(shí)間，但中國(guó)國(guó)家藥品監(jiān)督管理局已開通多條加速或簡(jiǎn)化通道，以方便新藥和疫苗或急需藥品的申請(qǐng)。

According to the company, the new vaccine is a replication-deficient vaccine based on a strain called MVA. The description is the same as Jynneos, the world's first mpox vaccine approved by the Food and Drug Administration in the United States in 2019.

據(jù)該公司介紹，這款新疫苗是一種基于MVA毒株的復(fù)制缺陷型疫苗。其描述與美國(guó)食品藥品監(jiān)督管理局2019年批準(zhǔn)的世界首款mpox疫苗Jynneos相同。

以上便是BBC新聞：國(guó)藥集團(tuán)mpox疫苗獲準(zhǔn)進(jìn)入臨床試驗(yàn)的相關(guān)內(nèi)容！通過了解這則新聞，可以學(xué)習(xí)相關(guān)的英語(yǔ)詞匯和短語(yǔ)。